Walker Asset Management LLC’s holdings in Pfizer were worth $349,000 at the end of the most recent reporting period. GKV Capital Management Co. Inc. purchased a new position in Pfizer during the first quarter valued at $27,000. North Capital Inc. purchased a new position in Pfizer during the first quarter valued at $28,000. Horizon Financial Services LLC purchased a new position in Pfizer during the first quarter valued at $35,000. Finally, WPG Advisers LLC purchased a new position in Pfizer during the first quarter valued at $35,000.